Peter Sorger

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Glencoe Software, Inc. provides scientific image data solutions. It products include OMERO Plus, Bio-Formats, PathViewer, DataViewer and Data InPress. The firm offers customization, support and data publishing services. The company was founded by Jason Swedlow in 2005 and is headquartered in Seattle, WA.

Applied BioMath LLC operates as a biotechnology company. The firm uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. It specializes in mechanistic PK/PD, quantitative decision making, risk assessments, predict optimal drug properties for lead gen or clinical candidate selection, phase 1 and phase 2 support and analysis, technical due diligence. The company was founded by John M. Burke, Joshua Apgar and Andrew Sutherland in 2013 and is headquartered in Concord, MA.